A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants

Clinical trial NCT04335539 · COMPLETED

Trial details

NCT number: NCT04335539
Sponsor: Shionogi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gram-negative Bacterial Infections Bloodstream Infections (BSI)Complicated Intra-abdominal Infection (cIAI)Hospital Acquired Pneumonia (HAP)Ventilator-acquired Pneumonia Complicated Urinary Tract Infection (cUTI)Sepsis

Start date: 2020-08-21
Primary completion: 2023-02-06
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.